Neuroem Therapeutics
Organization
People
Edward Culver Goodwin
Ceo
Sources: reporter.nih.gov
Grants and prizes
R44, Disaggregation of Toxic Protein Oligomers in Brain with ElectromagneticTreatment, R44AG073096, $984K, 2016–2024, Apr 10, 2023
Sources: reporter.nih.gov